Your session is about to expire
← Back to Search
Antibiotics for Rhinoplasty
Study Summary
This trial found that using both an intraoperative dose of either cephalexin or clindamycin, and a postoperative oral dose of either cephalexin or clindamycin, was more effective than using either drug alone in nasal surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had any type of surgical implants or grafts other than in the nose.I have had radiation therapy on my nose.I have had nose surgery before.I have a condition or take medication that weakens my immune system.I am 18 years old or older.
- Group 1: Treatment arm B
- Group 2: Treatment arm A
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there historical precedents for this proposed course of treatment?
"There are currently 28 ongoing clinical trials testing Treatment arm A. Of these, 8 have progressed to Phase 3. The majority of the Vancouver-based clinical trials will soon be completed, however there are 138 locations worldwide still running tests for this treatment option."
How many people are currently involved in this clinical trial?
"Right now, this study isn't looking for new patients. The listing was created on May 20th, 2020 and updated October 26th, 2022. If you're interested in other studies, there are 18 trials related to nasal surgical procedures and 28 concerning Treatment arm A admitting patients right now."
What is the FDA's stance on Treatment arm A?
"Treatment arm A of this clinical trial has received a safety score of 3. This is because efficacy has been partially proven in Phase 3 trials and there is supporting data from multiple rounds of testing."
Are there any unfilled vacancies in this experiment for new participants?
"According to the website clinicaltrials.gov, this study is not presently recruiting patients. This trial was initially posted on May 20th, 2020 and was last updated on October 26th, 2020. Although this particular trial isn't searching for candidates right now, there are 46 other trials that are currently accepting patients."
What is the purpose of Treatment arm A?
"Treatment arm A is designed to target anaerobic bacteria, but can also be used to fight against acquired valvular dysfunction, surgically constructed systemic-pulmonary shunt, and viridans group streptococci."
Share this study with friends
Copy Link
Messenger